Pfizer SARS-CoV-2 BNT162b2 mRNA vaccination (BNT162b2) has no adverse effect on elective oocyte cryopreservation outcomes

RESEARCH QUESTION: Do elective oocyte cryopreservation outcomes in women 1–13 months after SARS-CoV-2 vaccination alter compared with unvaccinated women and do different time intervals between vaccination and ovarian stimulation impact these outcomes? DESIGN: This retrospective cohort study, conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Karavani, Gilad, Chill, Henry H., Dick, Aharon, Meirman, Cherut, Gutman-Ido, Einat, Herzberg, Shmuel, Ben-Meir, Assaf, Imbar, Tal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Reproductive Healthcare Ltd. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176203/
https://www.ncbi.nlm.nih.gov/pubmed/35953414
http://dx.doi.org/10.1016/j.rbmo.2022.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176203/
https://www.ncbi.nlm.nih.gov/pubmed/35953414
http://dx.doi.org/10.1016/j.rbmo.2022.06.001

Ejemplares similares